e.g. mhealth
Search Results (1 to 3 of 3 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 1 JMIR Cardio
- 1 JMIR Human Factors
- 1 JMIR mHealth and uHealth
- 0 Journal of Medical Internet Research
- 0 Medicine 2.0
- 0 Interactive Journal of Medical Research
- 0 iProceedings
- 0 JMIR Research Protocols
- 0 JMIR Medical Informatics
- 0 JMIR Public Health and Surveillance
- 0 JMIR Serious Games
- 0 JMIR Mental Health
- 0 JMIR Rehabilitation and Assistive Technologies
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Medical Education
- 0 JMIR Cancer
- 0 JMIR Challenges
- 0 JMIR Diabetes
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 JMIR Formative Research
- 0 Journal of Participatory Medicine
- 0 JMIR Dermatology
- 0 JMIR Pediatrics and Parenting
- 0 JMIR Aging
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Med
- 0 JMIRx Bio
- 0 JMIR Infodemiology
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR AI
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
Warfarin is a commonly prescribed oral anticoagulant for patients who have undergone cardiac surgery and remains the only guideline-endorsed anticoagulant for patients with mechanical heart valves. However, considerable interindividual variability exists in the response to warfarin, with patient age, BMI, concomitant medications, and genetic status imparting considerable influence on warfarin maintenance dose requirements [1-5].
JMIR Cardio 2023;7:e47262
Download Citation: END BibTex RIS
By providing key information to an expert nurse or pharmacist, they can support an individual prescribing clinician on the nuances of evidence-based anticoagulant use.
JMIR Hum Factors 2023;10:e49025
Download Citation: END BibTex RIS
While warfarin had been the only available oral anticoagulant for decades, 5 new direct oral anticoagulants have come to market in the United States since 2010, paralleled by an increase in outpatient anticoagulant use [5]. The proportion of ED visits due to anticoagulants has increased by 57% in that period, and anticoagulants now account for nearly 18% of all ADE-associated ED visits in the United States [1-4,6].
JMIR Mhealth Uhealth 2018;6(12):e11090
Download Citation: END BibTex RIS